What does CUSIP 67080M103 represent in this 13F holders report?

CUSIP 67080M103 is the security identifier for NRIX - Nurix Therapeutics, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held NRIX - Nurix Therapeutics, Inc. - COMMON STOCK in Q3 2021?

110 institutional investors reported NRIX - Nurix Therapeutics, Inc. - COMMON STOCK for Q3 2021. Use the holders table for investor-level position and value details.

Nurix Therapeutics, Inc. - COMMON STOCK (NRIX)

CUSIP: 67080M103

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class: Equity / COMMON STOCK
Shares outstanding: 102,616,132
Total 13F shares: 39,378,816
Share change: -527,004
Total reported value: $1,180,362,633
Price per share: $29.96
Number of holders: 110
Value change: -$11,970,711
Number of buys: 57
Number of sells: 44

Quarterly Holders Quick Answers

What is CUSIP 67080M103?
CUSIP 67080M103 identifies NRIX - Nurix Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2021
Previous quarter: Q2 2021

Recent filing periods for CUSIP 67080M103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of NRIX - Nurix Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	3.9%	4,051,478	$107,486,000	—	30 Jun 2021	13F
TRV GP III, LLC	13F	Company	3.3%	3,422,549	$90,800,000	—	30 Jun 2021	13F
Redmile Group, LLC	13F	Company	3.1%	3,190,077	$84,633,000	—	30 Jun 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	2.4%	2,454,082	$65,107,000	—	30 Jun 2021	13F
BlackRock Finance, Inc.	13F	Company	2%	2,086,616	$55,359,000	—	30 Jun 2021	13F
EcoR1 Capital, LLC	13F	Company	1.9%	1,967,950	$52,210,000	—	30 Jun 2021	13F
STATE STREET CORP	13F	Company	1.8%	1,859,468	$49,332,000	—	30 Jun 2021	13F
VANGUARD GROUP INC	13F	Company	1.4%	1,466,137	$38,896,000	—	30 Jun 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.4%	1,394,891	$37,007,000	—	30 Jun 2021	13F
Third Rock Ventures III, L.P.	3/4/5	10%+ Owner	— class O/S missing	3,509,348	$35,104,359	—	06 May 2021	3/4/5
Bain Capital Life Sciences Investors, LLC	13F	Company	1.3%	1,284,314	$34,073,000	—	30 Jun 2021	13F
Boxer Capital, LLC	13F	Company	1.2%	1,224,892	$32,496,000	—	30 Jun 2021	13F
Foresite Capital Management IV, LLC	13F	Company	1.2%	1,205,798	$31,990,000	—	30 Jun 2021	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	1.2%	1,200,000	$31,836,000	—	30 Jun 2021	13F
WASATCH ADVISORS LP	13F	Company	1.2%	1,194,615	$31,693,000	—	30 Jun 2021	13F
JENNISON ASSOCIATES LLC	13F	Company	0.9%	919,037	$24,382,000	—	30 Jun 2021	13F
Ponoi II Management, LLC	13F	Company	0.67%	686,274	$18,207,000	—	30 Jun 2021	13F
Ponoi Management, LLC	13F	Company	0.67%	686,274	$18,207,000	—	30 Jun 2021	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.66%	676,887	$17,958,000	—	30 Jun 2021	13F
FMR LLC	13F	Company	0.64%	658,617	$17,473,000	—	30 Jun 2021	13F
Of The University Of California Regents	13F	Individual	0.56%	571,212	$15,155,000	—	30 Jun 2021	13F
COLUMN GROUP L P	3/4/5	10%+ Owner	— class O/S missing	1,442,739	$14,431,862	—	07 May 2021	3/4/5
S.c.a. Candriam	13F	Individual	0.49%	507,287	$13,458,000	—	30 Jun 2021	13F
Foresite Capital Management V, LLC	13F	Company	0.44%	451,522	$11,979,000	—	30 Jun 2021	13F
MORGAN STANLEY	13F	Company	0.43%	443,038	$11,753,000	—	30 Jun 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.42%	425,986	$11,301,000	—	30 Jun 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.38%	394,757	$10,472,000	—	30 Jun 2021	13F
Rock Springs Capital Management LP	13F	Company	0.31%	315,350	$8,366,000	—	30 Jun 2021	13F
HARVARD MANAGEMENT CO INC	13F	Company	0.31%	314,762	$8,351,000	—	30 Jun 2021	13F
DAFNA Capital Management LLC	13F	Company	0.3%	306,320	$8,127,000	—	30 Jun 2021	13F
BESSEMER GROUP INC	13F	Company	0.3%	304,762	$8,085,000	—	30 Jun 2021	13F
ORBIMED ADVISORS LLC	13F	Company	0.29%	300,000	$7,959,000	—	30 Jun 2021	13F
NORTHERN TRUST CORP	13F	Company	0.29%	296,890	$7,877,000	—	30 Jun 2021	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.28%	285,880	$7,584,396	—	30 Jun 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.27%	280,852	$7,451,000	—	30 Jun 2021	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.24%	244,157	$6,477,000	—	30 Jun 2021	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.22%	224,686	$5,960,000	—	30 Jun 2021	13F
Jasper Ridge Partners, L.P.	13F	Company	0.18%	180,480	$4,788,000	—	30 Jun 2021	13F
CLOUGH CAPITAL PARTNERS L P	13F	Company	0.16%	168,800	$4,478,000	—	30 Jun 2021	13F
Euclidean Capital LLC	13F	Company	0.15%	154,426	$4,097,000	—	30 Jun 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.14%	148,759	$3,946,000	—	30 Jun 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.13%	129,888	$3,446,000	—	30 Jun 2021	13F
CITIGROUP INC	13F	Company	0.12%	122,511	$3,250,000	—	30 Jun 2021	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.1%	106,320	$2,821,000	—	30 Jun 2021	13F
TD ASSET MANAGEMENT INC	13F	Company	0.07%	68,962	$2,120,000	—	30 Jun 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.08%	78,690	$2,088,000	—	30 Jun 2021	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.08%	78,527	$2,083,000	—	30 Jun 2021	13F
Bank of New York Mellon Corp	13F	Company	0.08%	78,027	$2,070,000	—	30 Jun 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.05%	50,671	$1,344,000	—	30 Jun 2021	13F
Pierre Beaurang	3/4/5	Chief Business Officer	— mixed-class rows	127,558 mixed-class rows	$1,210,335	—	10 Aug 2021	3/4/5

Institutional Holders of Nurix Therapeutics, Inc. - COMMON STOCK (NRIX) as of Q3 2021

As of 30 Sep 2021, Nurix Therapeutics, Inc. - COMMON STOCK (NRIX) was held by 110 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,378,816 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, Redmile Group, LLC, BlackRock Inc., BAKER BROS. ADVISORS LP, TRV GP III, LLC, VANGUARD GROUP INC, STATE STREET CORP, Bain Capital Life Sciences Investors, LLC, WELLINGTON MANAGEMENT GROUP LLP, and BOXER CAPITAL, LLC. This page lists 110 institutional shareholders reporting positions in this security for the Q3 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders

103

Q3 2021 holders

110

Holder diff

Investor	Q2 2021 Shares	Q3 2021 Shares	Share Diff	Share Chg %	Q2 2021 Value $	Q3 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.